China Pharma Holdings Inc (CPHI) — Financial Flexibility Index
China Pharma Holdings Inc (CPHI) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of $-236.37K (operating CF $-236.99K minus capex $613.00) represents 0% of total liabilities ($7.49 Million). Check how aggressively does China Pharma Holdings Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
China Pharma Holdings Inc Financial Flexibility Index (2001–2024)
Historical Financial Flexibility Index trend for China Pharma Holdings Inc across 24 annual periods. For the full cash flow conversion analysis, see China Pharma Holdings Inc cash flow conversion.
Annual Financial Flexibility Index for China Pharma Holdings Inc (2001–2024)
Year-by-year free cash flow to debt coverage for China Pharma Holdings Inc. Explore China Pharma Holdings Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.02x | $-174.64K | $-466.36K | $7.14 Million | ▲ +68.0% |
| 2023 | -0.08x | $-688.17K | $-699.69K | $9.01 Million | ▼ -13488.4% |
| 2022 | 0.00x | $-7.58K | $-409.55K | $13.49 Million | ▼ -105.0% |
| 2021 | 0.01x | $188.22K | $-249.84K | $16.63 Million | ▼ -82.0% |
| 2020 | 0.06x | $825.05K | $-42.26K | $13.11 Million | ▲ +9.9% |
| 2019 | 0.06x | $744.32K | $608.31K | $13.00 Million | ▼ -33.6% |
| 2018 | 0.09x | $1.31 Million | $1.26 Million | $15.18 Million | ▲ +48.8% |
| 2017 | 0.06x | $977.70K | $841.22K | $16.88 Million | ▼ -63.2% |
| 2016 | 0.16x | $3.09 Million | $2.90 Million | $19.61 Million | ▼ -31.7% |
| 2015 | 0.23x | $5.67 Million | $3.35 Million | $24.58 Million | ▼ -42.8% |
| 2014 | 0.40x | $10.42 Million | $4.57 Million | $25.83 Million | ▼ -64.1% |
| 2013 | 1.12x | $27.69 Million | $8.60 Million | $24.67 Million | ▲ +91.5% |
| 2012 | 0.59x | $8.63 Million | $3.64 Million | $14.72 Million | ▼ -24.4% |
| 2011 | 0.78x | $10.78 Million | $5.24 Million | $13.91 Million | ▼ -41.5% |
| 2010 | 1.33x | $18.30 Million | $7.79 Million | $13.81 Million | ▼ -46.3% |
| 2009 | 2.47x | $26.03 Million | $10.67 Million | $10.54 Million | ▼ -8.0% |
| 2008 | 2.68x | $15.04 Million | $6.54 Million | $5.60 Million | ▲ +82.8% |
| 2007 | 1.47x | $5.79 Million | $2.80 Million | $3.94 Million | ▲ +828.5% |
| 2006 | -0.20x | $-1.54 Million | $-1.74 Million | $7.66 Million | ▼ -103.1% |
| 2005 | 6.55x | $448.32K | $-35.81K | $68.41K | ▲ +1351.9% |
| 2004 | -0.52x | $-35.81K | $-35.81K | $68.41K | ▼ -480.5% |
| 2003 | -0.09x | $-93.13K | $-93.13K | $1.03 Million | ▲ +70.1% |
| 2002 | -0.30x | $-299.20K | $-299.20K | $992.02K | ▲ +0.0% |
| 2001 | -0.30x | $-299.20K | $-299.20K | $992.02K | — |